Close

Search

Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
SPECIAL ANNOUNCEMENT
2016 Photonics Buyers' Guide Clearance! – Use Coupon Code FC16 to save 60%!
share
Email Facebook Twitter Google+ LinkedIn Comments

Imaging Diagnostic Installs CTLM System in Mexico City

Photonics.com
Oct 2001
FORT LAUDERDALE, Fla., Oct. 10 -- Imaging Diagnostic Systems Inc. has installed its CTLM system into the Instituto Nacional de Cancerologia Cancer Institute in Mexico. Imaging Diagnostic’s breast imaging system employs state-of-the-art laser technology and proprietary and patented algorithms to create three-dimensional cross-sectional images of the breast.

Yolanda Villasenor, chief radiologist of the Breast Cancer Center at Instituto Nacional de Cancerologia, will assist Imaging Diagnostics to obtain clinical data to further substantiate its Pre-Market Approval (PMA) application, facilitate the clinical atlas, and be a promotional site for sales prospects.

``The placement of our CTLM system in this renowned cancer institute will serve as a platform for introducing our technology to Latin America,'' said Imaging Diagnostic Systems CEO Linda B. Grable.

Imaging Diagnostics has received CE Marking, UL listing, and ISO 9002 certification in order to market its product internationally. It is seeking a PMA from the Food and Drug Administration (FDA) in order for its CTLM system to be used as an adjunct to mammography in detecting breast abnormalities. The company's PMA application has been divided into different modules, each of which will contain documentation required for the FDA review. It has now submitted four out of the five modules required for the FDA approval process.



Comments
Terms & Conditions Privacy Policy About Us Contact Us
back to top

Facebook Twitter Instagram LinkedIn YouTube RSS
©2016 Photonics Media
x We deliver – right to your inbox. Subscribe FREE to our newsletters.